Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.30 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.30 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12036570 | 0.82 | TP53 (0.38) | ALDH1A1MAPTCYP1A2CSNK2A2CSNK2B | |
| SCHEMBL12036579 | 0.79 | HSD17B1 (0.36) | ALDH1A1MAPTCYP1A2CSNK2A2CSNK2B | |
| SCHEMBL31299941 | 0.75 | TP53 (0.41) | ALDH1A1MAPTCYP1A2CSNK2A2CSNK2B | |
| SCHEMBL6382158 | 0.74 | ALDH1A1 (0.40) | PSMB5MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL19383163 | 0.73 | BCHE (0.37) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL30777619 | 0.73 | KIF11 (0.46) | MAPTGRIA1CACNG8 | |
| SCHEMBL21461838 | 0.73 | KIF11 (0.46) | MAPTGRIA1CACNG8 | |
| SCHEMBL30467082 | 0.73 | GRIA1 (0.43) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL12264378 | 0.73 | GRIA1 (0.43) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL30122516 | 0.73 | ALDH1A1 (0.39) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8115378-B2 | Tetra-substituted chrysenes for luminescent applications | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-14 | — | — | US | disclosed |
| US-20090162693-A1 | TETRA-SUBSTITUTED CHRYSENES FOR LUMINESCENT APPLICATIONS | WELLS FARGO BANK, NATIONAL ASSOCIATION | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162693-A1 | TETRA-SUBSTITUTED CHRYSENES FOR LUMINESCENT APPLICATIONS | TEAD4, CRY2, TES | PSMB5 4820/4885MEN1 1331/4885ALDH1A1 3570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.